
About IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals is a Healthcare company based in Mountain View (United States) founded in 1994. Antibiotics for oral mucositis in head-and-neck cancer patients are developed. IntraBiotics Pharmaceuticals has raised $40.4 million across 3 funding rounds from investors including Orbimed, International Bio Medical and New England Capital Partners. Its focus areas include Life Sciences, Dental Disorders and Drugs. Its competitors include OraPharma, Marizyme and Acologix; 2 of its 3 listed competitors have raised funding.
Company details
IntraBiotics Pharmaceuticals was established in 1994 in Mountain View, United States, within the pharmaceuticals sector. Focus is placed on developing antibiotics to address oral mucositis in patients receiving radiotherapy for head-and-neck malignancies. The lead product, iseganan HCl, a synthetic peptide exhibiting broad-spectrum antimicrobial properties, is undergoing a pivotal Phase III clinical trial. Operations center on advancing treatments for radiotherapy-related complications.
- Headquarters Mountain View, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website intrabiotics.com
- Total Equity Funding$40.4M (USD)
in 3 rounds
- Latest Funding Round$3.5M (USD), Series B
Mar 2003
- InvestorsOrbimed
& 3 more
Funding Insights of IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals has successfully raised a total of $40.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $3.5 million completed in March 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $40.4M
- Total Rounds 3
- Last Round Series B β $3.5M
- First Round $23M
(Feb 1999)
- Investors Count 4
All 3 funding rounds of IntraBiotics Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2003 | $3.5M | Series B | β | β | β |
| Jan 2002 | $13.9M | Series B | β | β | β |
| Feb 1999 | $23M | Series B | β | International Bio Medical |
4 investors in total: 4 institutional.
Investors in IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, International Bio Medical and New England Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
A private investment firm focused on acquiring operating companies. | 1991 | necapitalpartners.com | Newton, United States | |
Portfolio of medical devices | 1974 | int-bio.com | Austin, United States | |
Economic mobility is supported through grants and community programs. | kauffmanfund.org | Kansas City, United States |
Investor details for IntraBiotics Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IntraBiotics Pharmaceuticals
3 dated milestones of IntraBiotics Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.
- Founded IntraBiotics Pharmaceuticals is founded.
- Funding First funding round of $23.0M.
- Funding Latest funding round, Series B, of $3.5M.
Competitors of IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include OraPharma, Marizyme and Acologix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orapharma.com | 1997 | Bridgewater, United States | $16M | Oral health products for treatment and maintenance are developed. | ||
| marizyme.com | 2007 | Woodstock, United States | 11 | Therapies for chronic wounds, thrombolysis, and dental health are developed. | ||
| acologix.com | 1992 | Hayward, United States | $69.8M | 13 | Therapeutics are developed for kidney and bone metabolic disorders. |
Detailed competitors of IntraBiotics Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dental Disorders
3 companies that operate in the same segment as IntraBiotics Pharmaceuticals (Dental Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Custom 3D printed dental aligners are developed for teeth straightening. | 2017 | New York, New York, United States | USD 147.78 M | |||
Invisalign clear aligners and dental products are developed. | 1997 | Tempe, Arizona, United States | USD 101 M | 1,051 | ||
Optical equipment for micron-level surface geometry capture is offered. | 2011 | Waltham, Massachusetts, United States | USD 16.22 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals was founded in 1994 and raised its 1st funding round 5 years after it was founded.
IntraBiotics Pharmaceuticals is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
IntraBiotics Pharmaceuticals is a funded company, having raised a total of $40.4M across 3 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Feb 1999.
IntraBiotics Pharmaceuticals was established in 1994 in Mountain View, United States, within the pharmaceuticals sector. Focus is placed on developing antibiotics to address oral mucositis in patients receiving radiotherapy for head-and-neck malignancies. The lead product, iseganan HCl, a synthetic peptide exhibiting broad-spectrum antimicrobial properties, is undergoing a pivotal Phase III clinical trial. Operations center on advancing treatments for radiotherapy-related complications.
IntraBiotics Pharmaceuticals has 4 investors. Key investors include Orbimed, International Bio Medical, New England Capital Partners, and Kauffman Foundation.